
1. malar j. 2015 dec 8;14:493. doi: 10.1186/s12936-015-1008-5.

beninese children cerebral malaria develop humoral immunity against
the it4-var19-dc8 pfemp1 variant linked epcr brain endothelial binding.

nunes-silva s(1)(2)(3)(4), dechavanne s(5)(6)(7)(8), moussiliou a(9)(10)(11),
pstrąg n(12)(13)(14)(15), semblat jp(16)(17)(18)(19), gangnard s(20)(21)(22)(23),
tuikue-ndam n(24)(25)(26), deloron p(27)(28)(29), chêne a(30)(31)(32)(33), gamain
b(34)(35)(36)(37).

author information: 
(1)inserm umr_1134, paris, france. ana-sofia.nunes-da-silva@inserm.fr.
(2)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
ana-sofia.nunes-da-silva@inserm.fr.
(3)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015, 
paris, france. ana-sofia.nunes-da-silva@inserm.fr.
(4)laboratory excellence gr-ex, paris, france.
ana-sofia.nunes-da-silva@inserm.fr.
(5)inserm umr_1134, paris, france. sebdechavanne@gmail.com.
(6)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
sebdechavanne@gmail.com.
(7)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015, 
paris, france. sebdechavanne@gmail.com.
(8)laboratory excellence gr-ex, paris, france. sebdechavanne@gmail.com.
(9)laboratory excellence gr-ex, paris, france. azizathmoussiliou@yahoo.fr.
(10)institut de recherche pour le développement, umr_216, mère et enfant face aux
infections tropicales, paris, france. azizathmoussiliou@yahoo.fr.
(11)faculté de pharmacie, pres sorbonne paris cité, paris, france.
azizathmoussiliou@yahoo.fr.
(12)inserm umr_1134, paris, france. natalia.pstrag@gmail.com.
(13)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
natalia.pstrag@gmail.com.
(14)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015,
paris, france. natalia.pstrag@gmail.com.
(15)laboratory excellence gr-ex, paris, france. natalia.pstrag@gmail.com.
(16)inserm umr_1134, paris, france. jean-philippe.semblat@inserm.fr.
(17)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
jean-philippe.semblat@inserm.fr.
(18)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015,
paris, france. jean-philippe.semblat@inserm.fr.
(19)laboratory excellence gr-ex, paris, france.
jean-philippe.semblat@inserm.fr.
(20)inserm umr_1134, paris, france. stephane.gangnard@pasteur.fr.
(21)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
stephane.gangnard@pasteur.fr.
(22)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015,
paris, france. stephane.gangnard@pasteur.fr.
(23)laboratory excellence gr-ex, paris, france. stephane.gangnard@pasteur.fr.
(24)laboratory excellence gr-ex, paris, france. nicaise.ndam@ird.fr.
(25)institut de recherche pour le développement, umr_216, mère et enfant face aux
infections tropicales, paris, france. nicaise.ndam@ird.fr.
(26)faculté de pharmacie, pres sorbonne paris cité, paris, france.
nicaise.ndam@ird.fr.
(27)laboratory excellence gr-ex, paris, france. philippe.deloron@ird.fr.
(28)institut de recherche pour le développement, umr_216, mère et enfant face aux
infections tropicales, paris, france. philippe.deloron@ird.fr.
(29)faculté de pharmacie, pres sorbonne paris cité, paris, france.
philippe.deloron@ird.fr.
(30)inserm umr_1134, paris, france. arnaud.chene@inserm.fr.
(31)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
arnaud.chene@inserm.fr.
(32)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015,
paris, france. arnaud.chene@inserm.fr.
(33)laboratory excellence gr-ex, paris, france. arnaud.chene@inserm.fr.
(34)inserm umr_1134, paris, france. benoit.gamain@inserm.fr.
(35)université paris diderot, sorbonne paris cité, umr_s1134, paris, france.
benoit.gamain@inserm.fr.
(36)institut national de la transfusion sanguine, 6 rue alexandre cabanel, 75015,
paris, france. benoit.gamain@inserm.fr.
(37)laboratory excellence gr-ex, paris, france. benoit.gamain@inserm.fr.

erratum in
    malar j. 2016;15:22.

background: malaria still one prevalent infectious diseases the
world. sequestration infected erythrocytes (ies) prime mediator of
disease. cytoadhesion ies mediated members highly diverse
plasmodium falciparum erythrocyte membrane protein 1 (pfemp1). restricted
sub-set var genes encoding pfemp1s possessing domain cassettes dc8 and
dc13 found bind endothelial protein c receptor (epcr). var
genes shown highly expressed parasites patients severe
malaria clinical outcomes compared patients uncomplicated
symptoms.
methods: order study molecular mechanisms underlying dc8/dc13
expressing ies adhesion epcr, method developed produce highly pure
recombinant epcr. it4 parasite strain selected either anti-it4-var19
purified igg, epcr human brain endothelial cell line var gene
expression profiles well binding phenotypes compared. the
n-terminal region it4-var19 comprising full-length dc8 cassette well as
the single epcr binding cidrα1.1 domain also produced, immune
recognition (igg) assessed using plasma samples beninese children
presenting acute mild malaria, severe malaria cerebral malaria time 
their admission clinic, convalescent-phase plasma collected 30
days anti-malarial treatment.
results: multi-domain var19-nts-dblγ6 binds epcr greater affinity
than cidrα1.1 domain alone study also demonstrates that
var19-nts-dblγ6 binding epcr-expressing endothelial cell line (hbec5i) 
more pronounced cidrα1.1 domain alone. it4-var19 represents 
preferentially expressed-pfemp1 fcr3-ies selected based their
capability bind epcr. notably, significant difference levels of
antibodies towards it4-var19 antigens observed within clinical groups
between plasma samples collected acute malaria phase compared to
samples collected 30 days anti-malaria treatment.
conclusions: data indicate even preferentially selected
it4-epcr-binding variant, it4-var19-dc8 region appear be
associated acquisition antibodies single severe paediatric
malaria episode benin.

doi: 10.1186/s12936-015-1008-5 
pmcid: pmc4672576
pmid: 26646943  [indexed medline]

